Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Míreanna comhchosúla

• Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
  de réir: Crook, A, et al.
  Foilsithe / Cruthaithe: (2016)
• Opportunities for improving the efficiency of paediatric HIV treatment programmes.
  de réir: Revill, P, et al.
  Foilsithe / Cruthaithe: (2015)
• A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa.
  de réir: Bwakura-Dangarembizi, M, et al.
  Foilsithe / Cruthaithe: (2014)
• Pubertal development in HIV-infected African children on first-line antiretroviral therapy.
  de réir: Szubert, A, et al.
  Foilsithe / Cruthaithe: (2015)
• Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW Trial.
  de réir: Musiime, V, et al.
  Foilsithe / Cruthaithe: (2010)